Standout Papers
- Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial (2019)
- Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial (2020)
Immediate Impact
3 by Nobel laureates 1 from Science/Nature 54 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Succinate Nanomaterials Boost Tumor Immunotherapy via Activating Cell Pyroptosis and Enhancing MHC-I Expression
2025 Standout
Works of Vidya Maiya being referenced
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
2020 Standout
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
2019 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Vidya Maiya | 1366 | 471 | 100 | 511 | 13 | 1.6k | |
| Rita Nanda | 1163 | 387 | 54 | 292 | 22 | 1.4k | |
| Iris Schrader | 1793 | 388 | 127 | 856 | 27 | 2.1k | |
| Shilpen Patel | 944 | 332 | 59 | 405 | 19 | 1.2k | |
| Christian von Törne | 1442 | 246 | 101 | 548 | 8 | 1.9k | |
| Stephen J. Luen | 939 | 339 | 80 | 301 | 32 | 1.3k | |
| Maarten Slagter | 1358 | 395 | 102 | 361 | 9 | 1.9k | |
| Daniel Carvajal‐Hausdorf | 1513 | 629 | 80 | 297 | 32 | 1.9k | |
| Gert Van den Eynden | 861 | 295 | 79 | 373 | 35 | 1.3k | |
| Davis Y. Torrejon | 1349 | 454 | 88 | 226 | 16 | 1.9k | |
| Joseph McLaughlin | 1120 | 567 | 59 | 199 | 13 | 1.3k |
All Works
Loading papers...